Blue Bell Private Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $120K | Sell |
476
-464
| -49% | -$99.8K | 0.01% | 332 |
|
|
2026
Q1 | $205K | Buy |
940
+530
| +129% | +$118K | 0.03% | 266 |
|
|
2025
Q4 | $93.6K | Buy |
410
+117
| +40% | +$26.7K | 0.01% | 337 |
|
|
2025
Q3 | $67.8K | Sell |
293
-234
| -44% | -$47.7K | 0.01% | 365 |
|
|
2025
Q2 | $97.8K | Buy |
527
+303
| +135% | +$56.3K | 0.02% | 309 |
|
|
2025
Q1 | $46.8K | Buy |
224
+1
| +0.4% | +$194 | 0.01% | 384 |
|
|
2024
Q4 | $39.5K | Buy |
223
+52
| +30% | +$9.56K | 0.01% | 385 |
|
|
2024
Q3 | $33.8K | Sell |
171
-26
| -13% | -$4.85K | 0.01% | 408 |
|
|
2024
Q2 | $33.9K | Sell |
197
-95
| -33% | -$15.7K | 0.01% | 403 |
|
|
2024
Q1 | $53.2K | Buy |
292
+5
| +2% | +$862 | 0.01% | 345 |
|
|
2023
Q4 | $44.5K | Buy |
287
+1
| +0.3% | +$146 | 0.01% | 338 |
|
|
2023
Q3 | $42.6K | Buy |
286
+81
| +40% | +$11.9K | 0.01% | 277 |
|
|
2023
Q2 | $27.6K | Buy |
205
+1
| +0.5% | +$147 | 0.01% | 321 |
|
|
2023
Q1 | $32.5K | Buy |
204
+1
| +0.5% | +$153 | 0.01% | 266 |
|
|
2022
Q4 | $32.8K | Buy |
203
+1
| +0.5% | +$153 | 0.01% | 254 |
|
|
2022
Q3 | $27K | Buy |
202
+35
| +21% | +$5.02K | 0.01% | 265 |
|
|
2022
Q2 | $26K | Buy |
167
+10
| +6% | +$1.53K | 0.01% | 278 |
|
|
2022
Q1 | $25K | Buy |
157
+1
| +0.6% | +$145 | 0.01% | 293 |
|
|
2021
Q4 | $21K | Buy |
+156
| New | +$18.4K | 0.01% | 298 |
|
|
2016
Q4 | – | Sell |
-255
| Closed | -$17K | – | 269 |
|
|
2016
Q3 | $17K | Hold |
255
| – | – | 0.01% | 305 |
|
|
2016
Q2 | $16K | Hold |
255
| – | – | 0.01% | 312 |
|
|
2016
Q1 | $15K | Sell |
255
-265
| -51% | -$14.8K | 0.01% | 321 |
|
|
2015
Q4 | $31K | Hold |
520
| – | – | 0.02% | 259 |
|
|
2015
Q3 | $28K | Hold |
520
| – | – | 0.02% | 273 |
|
|
2015
Q2 | $35K | Hold |
520
| – | – | 0.02% | 257 |
|
|
2015
Q1 | $30K | Hold |
520
| – | – | 0.02% | 266 |
|
|
2014
Q4 | $34K | Hold |
520
| – | – | 0.02% | 263 |
|
|
2014
Q3 | $30K | Hold |
520
| – | – | 0.02% | 295 |
|
|
2014
Q2 | $29K | Hold |
520
| – | – | 0.02% | 281 |
|
|
2014
Q1 | $27K | Hold |
520
| – | – | 0.02% | 259 |
|
|
2013
Q4 | $27K | Buy |
+520
| New | +$25.6K | 0.02% | 268 |
|
Other funds holding ABBV
Blue Bell Private Wealth Management's ABBV Position: Q2 2026 in Review
Blue Bell Private Wealth Management reduced its AbbVie (ABBV) stake by 49% in Q2 2026, selling an estimated $99.8K and leaving 476 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #332.
Blue Bell Private Wealth Management first reported a position in ABBV in Q4 2013 and has held it in 31 quarters since. The position peaked at $205K in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Blue Bell Private Wealth Management held 476 shares of AbbVie worth $120K as of Q2 2026.
- Blue Bell Private Wealth Management sold 464 AbbVie shares in Q2 2026, an estimated $99.8K.
- AbbVie made up 0.01% of Blue Bell Private Wealth Management's portfolio in Q2 2026, its #332 holding.
- Blue Bell Private Wealth Management first reported a position in AbbVie in Q4 2013 and has held it in 31 quarters since.
- Blue Bell Private Wealth Management's AbbVie position peaked at $205K in Q1 2026.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.